About the CTN DI Initiative
The CTN Dissemination Initiative aims to reduce the gap that exists between the publication of research on treatment of substance use disorders and implementation in clinical practice. It incorporates collaboration among clinicians, researchers, and experienced trainers to develop user-friendly tools and products to facilitate the adoption of research-based interventions into clinical settings. Explore this page for more information about the different components of the CTN Dissemination Initiative.
The CTN Dissemination Initiative is a component of the Clinical Trials Network within NIDA and works in collaboration with NIDAMED to develop products and disseminate those products to clinicians.
Products and Materials
In the addiction field, research is primarily translated into clinical practice through products and materials. We work with NIDA researchers and other experts to develop resources based on NIDA-supported research.
- The Tobacco, Alcohol, Prescription medication, and other Substance Use (TAPS) Tool is validated for use with adults to generate a risk level for each substance class. It can be self-administered or conducted via clinician interview and combines screening and brief assessment of past 90-day problematic use into one tool.
- For validated online screening tools for adolescents, visit NIDAMED’s Screening Tools for Adolescent Substance Use. These tools will help you assess substance use disorder risks among adolescents 12-17 years old.
- Implementing Drug and Alcohol Screening in Primary Care. Also, please view the fact sheet to learn about how to implement drug and alcohol screening.
Health Professions Education
This video was created in collaboration with staff from the University of Pennsylvania Center for Addiction Medicine and Policy in response to the more than 80 thousand opioid overdose deaths that occurred in 2020 largely driven by the illegally produced fentanyl that contaminates illegally produced opioids and benzodiazepines, as well as cocaine and synthetic cannabinoids. It also stresses that everyone can be a first responder by carrying naloxone. An infographic, is also available.
Medication Treatment Options for Methamphetamine Use Disorder
Despite the increase in methamphetamine overdose deaths in the United States between the years 2019 and 2020, effective medication treatment options for methamphetamine use disorder did not exist until now. This CME podcast describes the personal and societal burdens of methamphetamine use disorder in the United States, discusses the findings from the Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Disorder (ADAPT-2) clinical trial, and stresses the need for adopting these pharmacological treatment options for methamphetamine use disorder.
To learn more, please view this fact sheet.
- Buprenorphine Initiation for Opioid Use Disorders in Emergency Departments: Interactive Case Vignettes – Educational tool from The American College of Emergency Physicians
- Overdose Prevention Education for Clinicians Treating Patients with Opioids for Chronic Pain – Video from NIDA’s Center for the Clinical Trials Network
- Overdose Prevention Education for Clinicians Treating Patients for an Opioid Use Disorder – Video from NIDA’s Center for the Clinical Trials Network
- Learn about Initiating Buprenorphine Treatment in the Emergency Department and get step-by-step information, resources, discharge instructions, and videos.
- Facts for Medication Treatment for OUD – Video from NIDA’s Clinical Trials Network Dissemination Initiative
- Collaborative Care Approaches for Management of OUD – Harvard Medical School Global Academy and NIDA’s Center for the Clinical Trials Network
- Identification, Counseling, and Treatment of OUD — Harvard Medical School Global Academy and NIDA’s Center for Clinical Trials Network
- Understanding Addiction – Harvard Medical School Global Academy and NIDA’s Center for Clinical Trials Network
- Case Challenges in Opioid Use Disorder: Use of Medication Treatment – Clinical Trials Dissemination Initiative and Medscape
Products & Materials from the Blending Initiative
Blending Teams, consisting of NIDA researchers, treatment practitioners, trainers from SAMHSA’s ATTC Network, NIDA staff, and subject matter and communications experts, work closely together to develop training curricula, manuals, tools, and other resource materials based on NIDA-supported research.
- Blending Initiative Motivational Interviewing (MI) CME/CE and Patient Simulation – Practical guidance for clinicians in effective MI techniques.
- HIV Rapid Testing in Substance Abuse Treatment Programs: Resources to Support On-Site Rapid Testing (2012)
- Buprenorphine Suite of Blending Products – Including training materials for addiction professionals, resources about buprenorphine for teens, and studies on opioid dependence and using buprenorphine during opioid withdrawal.
- Motivational Incentives Package: A Proven Approach to Treatment – Three user-friendly products to assist clinicians and researchers in utilizing and applying Motivational Incentives for treating substance use among patients.
- Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA:STEP) (2006)
- Treatment Planning M.A.T.R.S.: Utilizing the Addiction Severity Index (ASI) to Make Required Data Collection Useful (2005)
Meetings and Conferences
An important aspect of the CTN Dissemination Initiative involves Meetings and Conferences, where addiction researchers and treatment providers collaborate and exchange knowledge. These events may offer the following:
- CME/CE credit for various health professionals
- Skill-building workshops
- Lectures for audiences ranging from addiction professionals to emergency department physicians
- Opportunities to meet leadership and members of key organizations
- Partnership and collaboration opportunities
- Resource development
Mentored Training Awards
Background on the Program:
- The Mentor-Facilitated Training Awards (MFT) program was developed to enhance the trainee healthcare professional’s expertise in substance use disorder dissemination activities. Through the mentorship program, awardees are funded for a year to develop a project which addresses gaps in evidence-based knowledge in addiction and treatment of substance use disorders through a mentored experience. To learn more, please see our video on the program.
- The Mentor-Facilitated Training Awards (MFT) is a top priority of the NIDA CTN Dissemination Initiative in establishing partnerships with professional organizations serving the addiction treatment communities. The MFT program has partnered with several health care organizations since 2012, which include: American Academy of Child and Adolescent Psychiatry (AACAP), Society for Adolescent Health and Medicine (SAHM), American College of Emergency Physicians/Emergency Medicine Foundation (ACEP/EMF), Society of Teachers of Family Medicine (STFM), American Academy of Physician Assistants (AAPA), American Association of Colleges of Nursing (AACN), American Association of Nurse Practitioners (AANP), and Society of General Internal Medicine (SGIM).
- Awardees are provided opportunities to acquire evidence-based expertise and understanding in the treatment of substance use disorders and are supported in identifying and addressing innovative ways to educate and provide treatment. Previous Awardees have selected topics that focus on the treatment, screening, and prevention of SUDs involving (but not limited to) alcohol, tobacco, marijuana, and opioids.
- Awardees within the MFT program, disseminate their projects at their respective professional society annual meetings and often publish in a scientific journal. Many of the dissemination projects have resulted in the development of highly impactful training series, workshop curricula, and innovative technological tools/resources. The awardees also present their findings to peers cross collaboratively, within respective fields, and within their local communities.